Case: A Case of Pembrolizumab Induced Myocarditis and Complete Heart Block.

Adhikari, Janak; Sharma, Priyadarshani; Karnabi, Eddy; Merchan, Juan H; Arshad, Hasnain

Adhikari, Janak; Sharma, Priyadarshani; Karnabi, Eddy; Merchan, Juan H; Arshad, Hasnain.

Afiliação

Adhikari J; Department of Internal Medicine, Eastern Maine Medical Center, Bangor, ME, USA.
Sharma P; Department of Internal Medicine, Eastern Maine Medical Center, Bangor, ME, USA.
Karnabi E; Department of Cardiology, Eastern Maine Medical Center, Bangor, ME, USA.
Merchan JH; Department of Cardiology, Eastern Maine Medical Center, Bangor, ME, USA.
Arshad H; Department of Neurology, Eastern Maine Medical Center, Bangor, ME, USA.

J Community Hosp Intern Med Perspect ; 14(3): 77-80, 2024.

Article em En | MEDLINE | ID: mdl-39036583

ABSTRACT

ABSTRACT

Use of checkpoint inhibitor pembrolizumab has continued to grow since its approval in 2014. Rare instances of conduction side effects have been described including brady and tachyarrhythmias, heart block and even cardiac arrest. We present a case of Pembrolizumab induced myocarditis and persistent third-degree heart block.

Palavras-chave

Heart block; Pembrolizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Community Hosp Intern Med Perspect Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google